These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

122 related articles for article (PubMed ID: 17312058)

  • 1. 1H MR spectroscopy in the assessment of gliomatosis cerebri.
    Guzmán-de-Villoria JA; Sánchez-González J; Muñoz L; Reig S; Benito C; García-Barreno P; Desco M
    AJR Am J Roentgenol; 2007 Mar; 188(3):710-4. PubMed ID: 17312058
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Multivoxel magnetic resonance spectroscopy in gliomatosis cerebri.
    Uysal E; Erturk M; Yildirim H; Karatag O; Can M; Tanik C; Basak M
    Acta Radiol; 2005 Oct; 46(6):621-4. PubMed ID: 16334845
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Differentiation between brain tumor recurrence and radiation injury using MR spectroscopy.
    Weybright P; Sundgren PC; Maly P; Hassan DG; Nan B; Rohrer S; Junck L
    AJR Am J Roentgenol; 2005 Dec; 185(6):1471-6. PubMed ID: 16304000
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Proton MR spectroscopy of gliomatosis cerebri: case report of elevated myoinositol with normal choline levels.
    Saraf-Lavi E; Bowen BC; Pattany PM; Sklar EM; Murdoch JB; Petito CK
    AJNR Am J Neuroradiol; 2003 May; 24(5):946-51. PubMed ID: 12748099
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Role of proton magnetic resonance spectroscopy in the diagnosis of gliomatosis cerebri: a unique pattern of normal choline but elevated Myo-inositol metabolite levels.
    Mohana-Borges AV; Imbesi SG; Dietrich R; Alksne J; Amjadi DK
    J Comput Assist Tomogr; 2004; 28(1):103-5. PubMed ID: 14716242
    [TBL] [Abstract][Full Text] [Related]  

  • 6. MR spectroscopy in gliomatosis cerebri.
    Bendszus M; Warmuth-Metz M; Klein R; Burger R; Schichor C; Tonn JC; Solymosi L
    AJNR Am J Neuroradiol; 2000 Feb; 21(2):375-80. PubMed ID: 10696026
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Noninvasive evaluation of cerebral glioma grade by using multivoxel 3D proton MR spectroscopy.
    Zeng Q; Liu H; Zhang K; Li C; Zhou G
    Magn Reson Imaging; 2011 Jan; 29(1):25-31. PubMed ID: 20832225
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Proton magnetic resonance spectroscopic findings of cerebral fat embolism induced by triolein emulsion in cats.
    Baik SK; Kim YW; Kim HJ; Lee JW; Cho BM; Kim DH; Choi SH; Lee SH; Chang KH
    Acta Radiol; 2008 Dec; 49(10):1174-81. PubMed ID: 19031181
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Spectroscopic evidence of cerebral axonopathy in patients with "pure" adrenomyeloneuropathy.
    Dubey P; Fatemi A; Barker PB; Degaonkar M; Troeger M; Zackowski K; Bastian A; Smith SA; Pomper MG; Moser HW; Raymond GV
    Neurology; 2005 Jan; 64(2):304-10. PubMed ID: 15668429
    [TBL] [Abstract][Full Text] [Related]  

  • 10. The value of proton MR-spectroscopy in the differentiation of brain tumours from non-neoplastic brain lesions.
    Aydin H; Sipahioğlu S; Oktay NA; Altin E; Kizilgöz V; Hekimoglu B
    JBR-BTR; 2011; 94(1):1-10. PubMed ID: 21466053
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Value of diagnosis and differential diagnosis of MRI and MR spectroscopy in gliomatosis cerebri.
    Yu A; Li K; Li H
    Eur J Radiol; 2006 Aug; 59(2):216-21. PubMed ID: 16769190
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Proton magnetic resonance spectroscopy in the distinction of high-grade cerebral gliomas from single metastatic brain tumors.
    Server A; Josefsen R; Kulle B; Maehlen J; Schellhorn T; Gadmar Ø; Kumar T; Haakonsen M; Langberg CW; Nakstad PH
    Acta Radiol; 2010 Apr; 51(3):316-25. PubMed ID: 20092374
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Measurements of diagnostic examination performance using quantitative apparent diffusion coefficient and proton MR spectroscopic imaging in the preoperative evaluation of tumor grade in cerebral gliomas.
    Server A; Kulle B; Gadmar ØB; Josefsen R; Kumar T; Nakstad PH
    Eur J Radiol; 2011 Nov; 80(2):462-70. PubMed ID: 20708868
    [TBL] [Abstract][Full Text] [Related]  

  • 14. MR spectroscopy using normalized and non-normalized metabolite ratios for differentiating recurrent brain tumor from radiation injury.
    Elias AE; Carlos RC; Smith EA; Frechtling D; George B; Maly P; Sundgren PC
    Acad Radiol; 2011 Sep; 18(9):1101-8. PubMed ID: 21820634
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Temporal window of metabolic brain vulnerability to concussion: a pilot 1H-magnetic resonance spectroscopic study in concussed athletes--part III.
    Vagnozzi R; Signoretti S; Tavazzi B; Floris R; Ludovici A; Marziali S; Tarascio G; Amorini AM; Di Pietro V; Delfini R; Lazzarino G
    Neurosurgery; 2008 Jun; 62(6):1286-95; discussion 1295-6. PubMed ID: 18824995
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Distinction between recurrent glioma and radiation injury using magnetic resonance spectroscopy in combination with diffusion-weighted imaging.
    Zeng QS; Li CF; Liu H; Zhen JH; Feng DC
    Int J Radiat Oncol Biol Phys; 2007 May; 68(1):151-8. PubMed ID: 17289287
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Evidence of reversible axonal dysfunction in systemic lupus erythematosus: a proton MRS study.
    Appenzeller S; Li LM; Costallat LT; Cendes F
    Brain; 2005 Dec; 128(Pt 12):2933-40. PubMed ID: 16195241
    [TBL] [Abstract][Full Text] [Related]  

  • 18. [Application of (1)H MR spectroscopic imaging in radiation oncology: choline as a marker for determining the relative probability of tumor progression after radiation of glial brain tumors].
    Lichy MP; Bachert P; Hamprecht F; Weber MA; Debus J; Schulz-Ertner D; Schlemmer HP; Kauczor HU
    Rofo; 2006 Jun; 178(6):627-33. PubMed ID: 16703499
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Metabolic changes in the normal ageing brain: consistent findings from short and long echo time proton spectroscopy.
    Gruber S; Pinker K; Riederer F; Chmelík M; Stadlbauer A; Bittsanský M; Mlynárik V; Frey R; Serles W; Bodamer O; Moser E
    Eur J Radiol; 2008 Nov; 68(2):320-7. PubMed ID: 17964104
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Use of proton magnetic resonance spectroscopy of the brain to differentiate gliomatosis cerebri from low-grade glioma.
    Galanaud D; Chinot O; Nicoli F; Confort-Gouny S; Le Fur Y; Barrie-Attarian M; Ranjeva JP; Fuentès S; Viout P; Figarella-Branger D; Cozzone PJ
    J Neurosurg; 2003 Feb; 98(2):269-76. PubMed ID: 12593610
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.